Piloting a Smartphone App to Improve Treatment Adherence Among South African Adolescents Living With HIV

NCT04661878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-06-13

Study results available
· View outcomes & findings →

Summary

The overall goal of this pilot randomized-controlled trial (RCT) is to pilot MASI (MAsakhane Siphucule Impilo Yethu; Xhosa for "Let's empower each other and improve our health"), an ART adherence-supporting smartphone app with 50 adolescents and young adults living with HIV to assess its feasibility and acceptability and to explore preliminary effects on ART adherence and social support.

Conditions

  • HIV Infections
  • Adolescent Behavior

Interventions

BEHAVIORAL

Social Support

The app will provide opportunities for participants to interact with each other as well as trained peer mentors to receive and provide social support.

BEHAVIORAL

Informational Resources

The app will provide opportunities for participants to review HIV-related health information in engaging formats (e.g., activities, multi-media resources, and answer to users' health questions)

BEHAVIORAL

Self-Monitoring and habit formation

The app will provide opportunities for participants to track their treatment adherence and schedule tailored reminders.

BEHAVIORAL

Goal setting and action planning

The app will provide opportunities for participants to identify goals, select action items, and receive tailored feedback on the action plan.

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Florida State University

    collaborator OTHER
  • Duke University

    lead OTHER

Principal Investigators

  • Marta I Mulawa, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2024-03-15
Completion
2024-04-02

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04661878 on ClinicalTrials.gov